On December 7, 2015 Foundation Medicine, Inc. (NASDAQ:FMI) reported that the company and its collaborators will present 10 poster presentations at the 2015 San Antonio Breast Cancer Symposium (SABCS) Annual Meeting taking place December 8-12, 2015 in San Antonio, Texas (Press release, Foundation Medicine, DEC 7, 2015, View Source [SID:1234508449]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company’s molecular information products, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient’s cancer. The data to be presented at SABCS provide further supporting evidence of the clinical utility of Foundation Medicine’s assays to identify emerging treatment options and inform efforts in treating breast cancer.

The schedule for poster presentations by Foundation Medicine and/or its collaborators is as follows:

Date and Time: Thursday, December 10, 2015, from 5:00-7:00 p.m. CT
Title: Non-Amplification ERBB2 Genomic Alterations in 5,605 Cases of Refractory and Metastatic Breast Cancer: an Emerging Opportunity for anti-HER2 Targeted Therapies
Poster Display Location: P3-07-05
Session: Prognostic and Predictive Factors: Response Predictions — Biomarkers and Other Factors
Presenter: Jeffrey S. Ross MD, Chairman, Dept. of Pathology and Laboratory Medicine, Albany Medical College and Medical Director, Foundation Medicine, Inc.
Collaborators: Albany Medical College, Mayo Clinic Cancer Center, Washington University

Date and Time: Thursday, December 10, 2015, from 5:00-7:00 p.m. CT
Title: Evolution of Genomic Alterations on Endocrine Therapy and mTOR Inhibition in Estrogen Receptor (ER)-Positive Breast Cancer
Poster Display Location: P3-05-06
Session: 3 – Tumor Cell and Molecular Biology: Endocrine Therapy and Resistance
Presenter: Suleiman Alfred Massarweh, MD Associate Professor of Medicine(Oncology) at the Stanford University Medical Center
Collaborators: Stanford University Medical School, Stanford Cancer Institute, University of Kentucky, Markey Cancer Center

Date and Time: Friday, December 11, 2015, from 5:00-7:00 p.m. CT
Title: Lapatinib Reverses Endocrine Resistance in Select Patients with HER 2 negative, Hormone Positive Metastatic Breast Cancer
Poster Display Location: P5-14-06
Session: 5 – Advanced Endocrine Therapy
Presenter: Priyanka Sharma, MD, Associate Professor of Medicine at University of Kansas
Collaborators: University of Kansas Medical Center, Hays Medical Center, Truman Medical Center

Date and Time: Friday, December 11, 2015, from 5:00 -7:00 p.m. CT
Title: Individualized molecular analyses guide efforts in breast cancer with comprehensive genomic profiling of tissue and plasma tumor DNA
Poster Display Location: PD6-08
Session: Translational Genomics
Presenter: Heather Parsons, MD, MPH Instructor in Medicine, Harvard Medical School at Dana Farber Cancer Institute
Collaborators: Dana-Farber Cancer Institute, Johns Hopkins Medical Institutions (JHMI)

Date and Time: Saturday, December 12, 2015, from 7:30-9:00 a.m. CT
Title: Comprehensive Genomic Profiling of Clinically Advanced Mucinous Carcinoma of the Breast
Poster Display Location: P6-03-12
Session: Tumor Cell and Molecular Biology: Genomics
Presenter: Jeffrey S. Ross MD, Chairman, Dept. of Pathology and Laboratory Medicine, Albany Medical College and Medical Director, Foundation Medicine, Inc.
Collaborators: Albany Medical College

Date and Time: Saturday, December 12, 2015, from 7:30-9:00 a.m. CT
Title: Clinicopathologic Characterization and Comprehensive Genomic Profiling (CGP) of Advanced Breast Cancer Patients with Fibroblast Growth Factor Receptor (FGFR) Alterations
Poster Display Location: P6-07-06
Session: 6 – Tumor Cell and Molecular Biology: Genetics — Somatic Changes
Presenter: Ricardo Alvarez, MD, MSc , Director of Cancer Research & Breast Medical Oncologist, Southeastern Regional Medical Center, CTCA
Collaborators: Cancer Treatment Centers of America

Date and Time: Saturday, December 12, 2015, from 7:30-9:00 a.m. CT
Title: EGFR Genomic Alterations in 5,605 Cases of Refractory and Metastatic Breast Cancer
Poster Display Location: P6-03-02
Session: 6 – Tumor Cell and Molecular Biology: Genetics — Somatic Changes
Presenter: Siraj M. Ali MD, PhD, Director Clinical Development, Foundation Medicine
Collaborators: Houston Methodist Hospital